{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:12:25Z","timestamp":1791220345682,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"IRBA"},{"name":"DGA"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.antiviral.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T05:44:09Z","timestamp":1427780649000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules"],"prefix":"10.1016","volume":"118","author":[{"given":"O.","family":"Ferraris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Moroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferrier Rembert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Paranhos-Baccal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.N.","family":"Peyrefitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.antiviral.2015.03.005_b0005","first-page":"1377","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Armor","year":"2002","journal-title":"Am. Acad. Ophthalmol."},{"issue":"21","key":"10.1016\/j.antiviral.2015.03.005_b0010","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.03.005_b0020","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"Bereczky","year":"2010","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2015.03.005_b0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004180000231","article-title":"Colocalization of beta 1,4 galactosyltransferase with mannose 6-phosphate receptor in monensin-induced TGN derived structures","volume":"115","author":"Berger","year":"2001","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2010.02.015","article-title":"Ebola virus uses clathrin-mediated endocytosis as an entry pathway","volume":"401","author":"Bhattacharyya","year":"2010","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.antiviral.2015.03.005_b0035","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1128\/JVI.00024-06","article-title":"Hepatitis C virus entry depends on clathrin-mediated endocytosis","volume":"80","author":"Blanchard","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1964.tb01570.x","article-title":"Studies on the hyperglycaemia induced by chlorpromazine in rats","volume":"23","author":"Bonaccorsi","year":"1964","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.antiviral.2015.03.005_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"9","key":"10.1016\/j.antiviral.2015.03.005_b0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/cup.12182","article-title":"Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases","volume":"40","author":"De Andrade","year":"2013","journal-title":"J. Cutan. Pathol."},{"issue":"8","key":"10.1016\/j.antiviral.2015.03.005_b0055","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"De Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"39","key":"10.1016\/j.antiviral.2015.03.005_b0060","first-page":"1","article-title":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses","volume":"4","author":"Di Trani","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2015.03.005_b0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jgm.1453","article-title":"Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir","volume":"12","author":"Diaconu","year":"2010","journal-title":"J. Gene Med."},{"issue":"9","key":"10.1016\/j.antiviral.2015.03.005_b0070","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.03.005_b0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Erg\u00f6n\u00fcl","year":"2006","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3201\/eid1801.111040","article-title":"Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010","volume":"18","author":"Estrada-Pena","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.03.005_b0090","doi-asserted-by":"crossref","first-page":"282734","DOI":"10.1155\/2013\/282734","article-title":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6\/36 cells","volume":"2013","author":"Farias","year":"2013","journal-title":"Sci. World J."},{"issue":"3","key":"10.1016\/j.antiviral.2015.03.005_b0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.taap.2012.11.030","article-title":"Chlorpromazine induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice","volume":"266","author":"Gandhi","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2013.05.030","article-title":"Crimean-Congo hemorrhagic fever virus utilizes a clathrin and early endosome dependent entry pathway","volume":"444","author":"Garrison","year":"2013","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.72.1.783-788.1998","article-title":"Mechanism of borna disease virus entry into cells","volume":"72","author":"Gonzalez-Dunia","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2014.04.005","article-title":"Crimean-Congo hemorrhagic fever infections reported by ProMED","volume":"26","author":"Ince","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.03.005_b0120","unstructured":"IPCS Inchem. <http:\/\/www.inchem.org\/documents\/pims\/pharm\/chloroqu.htm> (accessed 05.22.14)."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0974-9233.106404","article-title":"Delayed onset chloroquine retinopathy presenting 10years after long term usage of chloroquine","volume":"20","author":"Kazi","year":"2013","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.03.005_b0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikugunya virus in Vero cells","volume":"82","author":"Khan","year":"2010","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tripleo.2008.07.022","article-title":"Pigmentation of the hard palate","volume":"107","author":"Lerman","year":"2009","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.antiviral.2015.03.005_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205751","article-title":"Chloroquine cardiomyopathy: beyond ocular adverse effects","author":"Lopez-Ruiz","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.antiviral.2015.03.005_b0155","doi-asserted-by":"crossref","first-page":"e2804","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever","volume":"8","author":"Oestereich","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"39","key":"10.1016\/j.antiviral.2015.03.005_b0160","first-page":"1","article-title":"In vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2015.03.005_b0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1099\/vir.0.015701-0","article-title":"Differential activation profiles of Crimean-Congo hemorrhagic fever virus and Dugbe virus infected antigen presenting cells","volume":"91","author":"Peyrefitte","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1083\/jcb.90.3.665","article-title":"Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages","volume":"90","author":"Poole","year":"1981","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.antiviral.2015.03.005_b0175","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1128\/JVI.00164-09","article-title":"Simulating Henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy","volume":"83","author":"Porotto","year":"2009","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2015.03.005_b0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt1979261114","article-title":"Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness","volume":"26","author":"Rivera-Calimlim","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2015.03.005_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2015.03.005_b0195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(89)90421-2","article-title":"Verapamil and chlorpromazine inhibit the budding of Sindbis and vesicular stomatitis viruses from infected chicken embryo fibroblasts","volume":"168","author":"Schlesinger","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.03.005_b0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0757.2008.00226.x","article-title":"Oral and dental adverse drug reactions","volume":"46","author":"Seymour","year":"2008","journal-title":"Periodontology 2000"},{"key":"10.1016\/j.antiviral.2015.03.005_b0210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1099\/vir.0.006387-0","article-title":"Crimean-Congo hemorrhagic fever virus entry and replication is clathrin, pH, and cholesterol dependent","volume":"90","author":"Simon","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.03.005_b0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2015.03.005_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aid.1993.9.91","article-title":"Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes","volume":"9","author":"Sperber","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2015.03.005_b0225","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10096-009-0728-2","article-title":"The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising","volume":"28","author":"Tasdelen Fisgin","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2015.03.005_b0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy \u2013 a review of the literature","volume":"35","author":"T\u00f6nnesmann","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.antiviral.2015.03.005_b0235","first-page":"718","article-title":"A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients","volume":"68","author":"Van Eeden","year":"1985","journal-title":"S. Afr. Med. J."},{"issue":"8692","key":"10.1016\/j.antiviral.2015.03.005_b0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0140-6736(90)90906-L","article-title":"Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever","volume":"335","author":"Vassilenko","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.antiviral.2015.03.005_b0245","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.1983.tb02244.x","article-title":"Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria","volume":"16","author":"Walker","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.antiviral.2015.03.005_b0250","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"J. Cell Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T08:56:12Z","timestamp":1598864172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":47,"alternative-id":["S0166354215000571"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.03.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}